ACTINIUM PHARMACEUTICALS, INC. Shareholders' Equity
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Shareholders' Equity of $30.30 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $30.30M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.30M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $13.78M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $30.30M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.30M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $7.83M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $13.78M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $19.01M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $25.69M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $32.76M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $38.21M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $43.84M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $43.86M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $36.38M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $43.58M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $53.08M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $57.21M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $66.48M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $71.25M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $78.18M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $68.84M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $73.55M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $80.28M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $80.50M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $70.74M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $61.32M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $45.43M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $50.77M 10-Q · filed 2020-10-23 | |
| 2020-03-31 | $3.02M 10-Q · filed 2020-10-23 | |
| 2019-12-31 | $5.64M 10-K · filed 2021-03-31 | $5.64M 10-K · filed 2020-05-08 |
| 2019-09-30 | $9.94M 10-Q · filed 2020-10-23 | $9.94M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $15.70M 10-Q · filed 2020-10-23 | $15.70M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $5.34M 10-Q · filed 2020-10-23 | $5.34M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $8.81M 10-K · filed 2021-03-31 | $8.81M 10-K · filed 2019-03-15 |
| 2018-09-30 | $11.58M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $17.32M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $21.75M 10-Q · filed 2019-11-12 | $21.75M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $13.67M 10-K · filed 2020-05-08 | |
| 2017-09-30 | $18.19M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $8.87M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $12.88M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $18.01M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $14.23M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $19.08M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $20.06M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $21.97M 10-K · filed 2019-03-15 | |
| 2015-09-30 | $22.89M 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $23.28M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $16.44M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$1.92M 10-K · filed 2018-03-16 | |
| 2014-09-30 | $2.37M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $4.33M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$13.47M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$1.56M 10-K · filed 2017-03-16 | |
| 2013-09-30 | $604.33K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.91M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $550.81K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.15M 10-K · filed 2016-03-11 | -$1.15M 10-K · filed 2013-03-29 |
| 2012-09-30 | -$103.99K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$100.28K 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | -$93.96K 10-Q · filed 2012-04-23 | |
| 2011-12-31 | $992.01K 10-K · filed 2014-02-28 | -$84.33K 10-K · filed 2012-04-12 |
| 2011-09-30 | -$81.68K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$78.17K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $399.06K 10-K · filed 2014-02-28 | -$94.62K 10-Q · filed 2011-08-12 |
| 2009-12-31 | $845.16K 10-K · filed 2014-02-28 | |
| 2008-12-31 | $4.16M 10-K · filed 2014-02-28 | |
| 2007-12-31 | $3.46M 10-K · filed 2014-02-28 | |
| 2006-12-31 | $1.82M 10-K · filed 2014-02-28 | |
| 2005-12-31 | $74.28K 10-K · filed 2014-02-28 | |
| 2004-12-31 | $439.12K 10-K · filed 2014-02-28 | |
| 2003-12-31 | $1.57M 10-K · filed 2014-02-28 | |
| 2002-12-31 | -$1.68M 10-K · filed 2014-02-28 | |
| 2001-12-31 | -$1.73M 10-K · filed 2014-02-28 | |
| 2000-12-31 | $1.11M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |